{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T06:29:50Z","timestamp":1778135390391,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,18]],"date-time":"2020-01-18T00:00:00Z","timestamp":1579305600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,18]],"date-time":"2020-01-18T00:00:00Z","timestamp":1579305600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007184","name":"Pr\u00f3-Reitoria de Pesquisa, Universidade Federal do Rio Grande do Sul","doi-asserted-by":"publisher","award":["2017\/2018"],"award-info":[{"award-number":["2017\/2018"]}],"id":[{"id":"10.13039\/501100007184","id-type":"DOI","asserted-by":"publisher"}]},{"name":"PPGCF\/UFRGS","award":["2017\/2018"],"award-info":[{"award-number":["2017\/2018"]}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"crossref","award":["NSERC; RGPIN-2016-05867)"],"award-info":[{"award-number":["NSERC; RGPIN-2016-05867)"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Chercheur National- Scholarship from the Fonds de Recherche du Qu\u00e9bec \u2013 Sant\u00e9","award":["2018"],"award-info":[{"award-number":["2018"]}]},{"name":"CNPq (Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"Programa Nacional de Coopera\u00e7\u00e3o Acad\u00eamica","award":["158819"],"award-info":[{"award-number":["158819"]}]},{"name":"Programa de Coopera\u00e7\u00e3o com o Centro Internacional para Engenharia Gen\u00e9tica e Biotecnologia","award":["405231\/2015-6"],"award-info":[{"award-number":["405231\/2015-6"]}]},{"name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio Grande do Sul (BR) - PRONEX","award":["16\/2551-0000473-0"],"award-info":[{"award-number":["16\/2551-0000473-0"]}]},{"name":"Programa Nacional de Coopera\u00e7\u00e3o Acad\u00eamica","award":["158819"],"award-info":[{"award-number":["158819"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Purinergic Signalling"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s11302-019-09686-x","type":"journal-article","created":{"date-parts":[[2020,1,18]],"date-time":"2020-01-18T21:02:22Z","timestamp":1579381342000},"page":"29-40","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Imatinib mesylate affects extracellular ATP catabolism and expression of NTPDases in a chronic myeloid leukemia cell line"],"prefix":"10.1007","volume":"16","author":[{"given":"Julia Biz","family":"Willig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9bora Renz Barreto","family":"Vianna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aline","family":"Beckenkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liziane Raquel","family":"Beckenkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"S\u00e9vigny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rcia Ros\u00e2ngela","family":"Wink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9ia","family":"Buffon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diogo Andr\u00e9","family":"Pilger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,18]]},"reference":[{"key":"9686_CR1","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1038\/leu.2016.51","volume":"30","author":"M Wagle","year":"2016","unstructured":"Wagle M, Eiring AM, Wongchenko M et al (2016) A role for FOXO1 in BCR-ABL1-independent tyrosine kinase inhibitor resistance in chronic myeloid leukemia. Leukemia 30:1493\u20131501. https:\/\/doi.org\/10.1038\/leu.2016.51","journal-title":"Leukemia"},{"key":"9686_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2147\/OTT.S3993","volume":"2","author":"I Tamascar","year":"2009","unstructured":"Tamascar I, Ramanarayanan J (2009) Targeted treatment of chronic myeloid leukemia: role of imatinib. Onco Targets Ther 2:63\u201371. https:\/\/doi.org\/10.2147\/OTT.S3993","journal-title":"Onco Targets Ther"},{"key":"9686_CR3","doi-asserted-by":"crossref","unstructured":"Zhou T, Medeiros LJ, Hu S (2018) Chronic myeloid leukemia : beyond BCR-ABL1","DOI":"10.1007\/s11899-018-0474-6"},{"key":"9686_CR4","doi-asserted-by":"publisher","unstructured":"Mitchell S, Ferdinand T, Batson S (2012) Treatments for chronic myeloid leukemia: a qualitative systematic review. J Blood Med 51. https:\/\/doi.org\/10.2147\/JBM.S33380","DOI":"10.2147\/JBM.S33380"},{"key":"9686_CR5","first-page":"3343","volume":"96","author":"MWN Deininger","year":"2013","unstructured":"Deininger MWN, Goldman JM, Melo JV et al (2013) The molecular biology of chronic myeloid leukemia. Review article. Mol Biol Chron Myeloid Leuk 96:3343\u20133356","journal-title":"Mol Biol Chron Myeloid Leuk"},{"key":"9686_CR6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/sj.leu.2403257","volume":"18","author":"T Illmer","year":"2004","unstructured":"Illmer T, Schaich M, Platzbecker U, Freiberg-Richter J, Oelschl\u00e4gel U, von Bonin M, Pursche S, Bergemann T, Ehninger G, Schleyer E (2004) P-glycoprotein-mediated drug efflux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylate. Leukemia 18:401\u2013408. https:\/\/doi.org\/10.1038\/sj.leu.2403257","journal-title":"Leukemia"},{"key":"9686_CR7","doi-asserted-by":"publisher","unstructured":"Begicevic RR, Falasca M (2017) ABC transporters in cancer stem cells: beyond chemoresistance. Int J Mol Sci 18. https:\/\/doi.org\/10.3390\/ijms18112362","DOI":"10.3390\/ijms18112362"},{"key":"9686_CR8","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.3109\/10428194.2016.1142086","volume":"57","author":"BW Ko","year":"2016","unstructured":"Ko BW, Han J, Heo JY, Jang Y, Kim SJ, Kim J, Lee MJ, Ryu MJ, Song IC, Jo YS, Kweon GR (2016) Metabolic characterization of imatinib-resistant BCR-ABL T315I chronic myeloid leukemia cells indicates down-regulation of glycolytic pathway and low ROS production. Leuk Lymphoma 57:2180\u20132188. https:\/\/doi.org\/10.3109\/10428194.2016.1142086","journal-title":"Leuk Lymphoma"},{"key":"9686_CR9","doi-asserted-by":"crossref","unstructured":"Burnstock G, Kennedy C (1985) Review is there a basis for distinguishing types of P2-purinoceptor?","DOI":"10.1016\/0306-3623(85)90001-1"},{"key":"9686_CR10","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/onc.2016.206","volume":"36","author":"F Di Virgilio","year":"2017","unstructured":"Di Virgilio F, Adinolfi E (2017) Extracellular purines, purinergic receptors and tumor growth. Oncogene 36:293\u2013303. https:\/\/doi.org\/10.1038\/onc.2016.206","journal-title":"Oncogene"},{"key":"9686_CR11","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41568-018-0037-0","volume":"18","author":"F Di Virgilio","year":"2018","unstructured":"Di Virgilio F, Sarti AC, Falzoni S et al (2018) Extracellular ATP and P2 purinergic signalling in the tumour microenvironment. Nat Rev Cancer 18:601\u2013618. https:\/\/doi.org\/10.1038\/s41568-018-0037-0","journal-title":"Nat Rev Cancer"},{"key":"9686_CR12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/ddr.1097","volume":"52","author":"H Zimmermann","year":"2001","unstructured":"Zimmermann H (2001) Ectonucleotidases: some recent developments and a note on nomenclature. Drug Dev Res 52:44\u201356. https:\/\/doi.org\/10.1002\/ddr.1097","journal-title":"Drug Dev Res"},{"key":"9686_CR13","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11302-006-9003-5","volume":"2","author":"SC Robson","year":"2006","unstructured":"Robson SC, S\u00e9vigny J, Zimmermann H (2006) The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance. Purinergic Signal 2:409\u2013430. https:\/\/doi.org\/10.1007\/s11302-006-9003-5","journal-title":"Purinergic Signal"},{"key":"9686_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1139\/bcb-2013-0051","volume":"92","author":"A Beckenkamp","year":"2014","unstructured":"Beckenkamp A, Santana DB, Bruno AN et al (2014) Ectonucleotidase expression profile and activity in human cervical cancer cell lines. Biochem Cell Biol 92:95\u2013104. https:\/\/doi.org\/10.1139\/bcb-2013-0051","journal-title":"Biochem Cell Biol"},{"key":"9686_CR15","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.3892\/ol.2016.5189","volume":"12","author":"XY Cai","year":"2016","unstructured":"Cai XY, Wang XF, Li J, Dong JN, Liu JQ, Li NP, Yun B, Xia RL, Qin J, Sun YH (2016) High expression of CD39 in gastric cancer reduces patient outcome following radical resection. Oncol Lett 12:4080\u20134086. https:\/\/doi.org\/10.3892\/ol.2016.5189","journal-title":"Oncol Lett"},{"key":"9686_CR16","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.urolonc.2009.01.035","volume":"28","author":"J Stella","year":"2010","unstructured":"Stella J, Bavaresco L, Braganhol E et al (2010) Differential ectonucleotidase expression in human bladder cancer cell lines. Urol Oncol Semin Orig Investig 28:260\u2013267. https:\/\/doi.org\/10.1016\/j.urolonc.2009.01.035","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"9686_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s12307-018-0206-4","volume":"11","author":"APS Bertoni","year":"2018","unstructured":"Bertoni APS, de Campos RP, Tsao M, Braganhol E, Furlanetto TW, Wink MR (2018) Extracellular ATP is differentially metabolized on papillary thyroid carcinoma cells surface in comparison to normal cells. Cancer Microenviron 11:61\u201370. https:\/\/doi.org\/10.1007\/s12307-018-0206-4","journal-title":"Cancer Microenviron"},{"key":"9686_CR18","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/bjh.12774","volume":"165","author":"N Dulphy","year":"2014","unstructured":"Dulphy N, Henry G, Hemon P, Khaznadar Z, Dombret H, Boissel N, Bensussan A, Toubert A (2014) Contribution of CD39 to the immunosuppressive microenvironment of acute myeloid leukaemia at diagnosis. Br J Haematol 165:722\u2013725. https:\/\/doi.org\/10.1111\/bjh.12774","journal-title":"Br J Haematol"},{"key":"9686_CR19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/biof.5520310205","volume":"31","author":"MRC Schetinger","year":"2007","unstructured":"Schetinger MRC, Morsch VM, Bonan CD, Wyse ATS (2007) NTPDase and 5\u2032-nucleotidase activities in physiological and disease conditions: new perspectives for human health. BioFactors 31:77\u201398. https:\/\/doi.org\/10.1002\/biof.5520310205","journal-title":"BioFactors"},{"key":"9686_CR20","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1080\/10937404.2015.1051611.INHALATION","volume":"11","author":"W Guo","year":"2015","unstructured":"Guo W, Polich ED, Su J, Gao Y, Christopher DM, Allan AM, Wang M, Wang F, Wang G, Zhao X (2015) HHS public access. Cell Rep 11:1651\u20131666. https:\/\/doi.org\/10.1080\/10937404.2015.1051611.INHALATION","journal-title":"Cell Rep"},{"key":"9686_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.bushor.2014.08.001","volume":"10","author":"A Boyum","year":"1977","unstructured":"Boyum A (1977) Separation of lymphocytes, lymphocyte subgroups and monocytes: a review. Lymphology 10:71\u201376. https:\/\/doi.org\/10.1016\/j.bushor.2014.08.001","journal-title":"Lymphology"},{"key":"9686_CR22","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.canlet.2014.10.033","volume":"356","author":"W Wang","year":"2015","unstructured":"Wang W, Zhang J, Li Y, Yang X, He Y, Li T, Ren F, Zhang J, Lin R (2015) Divalproex sodium enhances the anti-leukemic effects of imatinib in chronic myeloid leukemia cells partly through SIRT1. Cancer Lett 356:791\u2013799. https:\/\/doi.org\/10.1016\/j.canlet.2014.10.033","journal-title":"Cancer Lett"},{"key":"9686_CR23","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/0003-2697(86)90640-8","volume":"157","author":"KM Chan","year":"1986","unstructured":"Chan KM, Delfert D, Junger KD (1986) A direct colorimetric assay for Ca2+-stimulated ATPase activity. Anal Biochem 157:375\u2013380. https:\/\/doi.org\/10.1016\/0003-2697(86)90640-8","journal-title":"Anal Biochem"},{"key":"9686_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.bbagen.2004.09.006","volume":"1721","author":"DBR Leal","year":"2005","unstructured":"Leal DBR, Streher CA, Neu TN et al (2005) Characterization of NTPDase (NTPDase1; ecto-apyrase; ecto-diphosphohydrolase; CD39; EC 3.6.1.5) activity in human lymphocytes. Biochim Biophys Acta Gen Subj 1721:9\u201315. https:\/\/doi.org\/10.1016\/j.bbagen.2004.09.006","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"9686_CR25","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248\u2013254. https:\/\/doi.org\/10.1016\/0003-2697(76)90527-3","journal-title":"Anal Biochem"},{"key":"9686_CR26","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s11302-017-9561-8","volume":"13","author":"J Pelletier","year":"2017","unstructured":"Pelletier J, Agonsanou H, Delvalle N, Fausther M, Salem M, Gulbransen B, S\u00e9vigny J (2017) Generation and characterization of polyclonal and monoclonal antibodies to human NTPDase2 including a blocking antibody. Purinergic Signal 13:293\u2013304. https:\/\/doi.org\/10.1007\/s11302-017-9561-8","journal-title":"Purinergic Signal"},{"key":"9686_CR27","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1742-4658.2008.06797.x","volume":"276","author":"MN Munkonda","year":"2009","unstructured":"Munkonda MN, Pelletier J, Ivanenkov VV, Fausther M, Tremblay A, K\u00fcnzli B, Kirley TL, S\u00e9vigny J (2009) Characterization of a monoclonal antibody as the first specific inhibitor of human NTP diphosphohydrolase-3. FEBS J 276:479\u2013496. https:\/\/doi.org\/10.1111\/j.1742-4658.2008.06797.x","journal-title":"FEBS J"},{"issue":"12","key":"9686_CR28","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1002\/cam4.1187","volume":"6","author":"S Avil\u00e9s-V\u00e1zquez","year":"2017","unstructured":"Avil\u00e9s-V\u00e1zquez S et al (2017) Global gene expression profiles of hematopoietic stem and progenitor cells from patients with chronic myeloid leukemia: the effect of in vitro culture with or without imatinib. Cancer Med 6(12):2942\u20132956. https:\/\/doi.org\/10.1002\/cam4.1187","journal-title":"Cancer Med"},{"key":"9686_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.scr.2018.01.038","volume":"28","author":"S Bono","year":"2018","unstructured":"Bono S, Dello Sbarba P, Lulli M (2018) Imatinib-mesylate enhances the maintenance of chronic myeloid leukemia stem cell potential in the absence of glucose. Stem Cell Res 28:33\u201338. https:\/\/doi.org\/10.1016\/j.scr.2018.01.038","journal-title":"Stem Cell Res"},{"key":"9686_CR30","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/sctm.17-0175","volume":"7","author":"E Arrigoni","year":"2018","unstructured":"Arrigoni E, Del Re M, Galimberti S et al (2018) Concise review: chronic myeloid leukemia: stem cell niche and response to pharmacologic treatment. Stem Cells Transl Med 7:305\u2013314. https:\/\/doi.org\/10.1002\/sctm.17-0175","journal-title":"Stem Cells Transl Med"},{"key":"9686_CR31","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s12015-018-9839-4","volume":"14","author":"RB Curtarelli","year":"2018","unstructured":"Curtarelli RB, Gon\u00e7alves JM, dos Santos LGP et al (2018) Expression of cancer stem cell biomarkers in human head and neck carcinomas: a systematic review. Stem Cell Rev Rep 14:769\u2013784. https:\/\/doi.org\/10.1007\/s12015-018-9839-4","journal-title":"Stem Cell Rev Rep"},{"key":"9686_CR32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1080\/02791072.1995.10472466","volume":"2","author":"MM Gottesman","year":"2002","unstructured":"Gottesman MM, Fojo T, Bates SE (2002) Multidrug resistance in cancer: role of Atp-dependent transporters. Nat Rev Cancer 2:48\u201358. https:\/\/doi.org\/10.1080\/02791072.1995.10472466","journal-title":"Nat Rev Cancer"},{"key":"9686_CR33","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.cbi.2014.06.009","volume":"219","author":"P Kosztyu","year":"2014","unstructured":"Kosztyu P, Bukvova R, Dolezel P, Mlejnek P (2014) Resistance to daunorubicin, imatinib, or nilotinib depends on expression levels of ABCB1 and ABCG2 in human leukemia cells. Chem Biol Interact 219:203\u2013210. https:\/\/doi.org\/10.1016\/j.cbi.2014.06.009","journal-title":"Chem Biol Interact"},{"key":"9686_CR34","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1158\/2326-6066.CIR-14-0018","volume":"3","author":"J Bastid","year":"2015","unstructured":"Bastid J, Regairaz A, Bonnefoy N, D\u00e9jou C, Giustiniani J, Laheurte C, Cochaud S, Laprevotte E, Funck-Brentano E, Hemon P, Gros L, Bec N, Larroque C, Alberici G, Bensussan A, Eliaou JF (2015) Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity. Cancer Immunol Res 3:254\u2013265. https:\/\/doi.org\/10.1158\/2326-6066.CIR-14-0018","journal-title":"Cancer Immunol Res"},{"key":"9686_CR35","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1182\/blood-2011-07-370775","volume":"119","author":"V Salvestrini","year":"2012","unstructured":"Salvestrini V, Zini R, Rossi L, Gulinelli S, Manfredini R, Bianchi E, Piacibello W, Caione L, Migliardi G, Ricciardi MR, Tafuri A, Romano M, Salati S, di Virgilio F, Ferrari S, Baccarani M, Ferrari D, Lemoli RM (2012) Purinergic signaling inhibits human acute myeloblastic leukemia cell proliferation, migration, and engraftment in immunodeficient mice. Blood 119:217\u2013226. https:\/\/doi.org\/10.1182\/blood-2011-07-370775","journal-title":"Blood"},{"key":"9686_CR36","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s11302-016-9510-y","volume":"12","author":"C Ledderose","year":"2016","unstructured":"Ledderose C, Woehrle T, Ledderose S, Strasser K, Seist R, Bao Y, Zhang J, Junger WG (2016) Cutting off the power: inhibition of leukemia cell growth by pausing basal ATP release and P2X receptor signaling? Purinergic Signal 12:439\u2013451. https:\/\/doi.org\/10.1007\/s11302-016-9510-y","journal-title":"Purinergic Signal"},{"key":"9686_CR37","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s11010-012-1513-6","volume":"374","author":"D Zanini","year":"2013","unstructured":"Zanini D, Schmatz R, Pelinson LP, Pimentel VC, da Costa P, Cardoso AM, Martins CC, Schetinger CC, Baldissareli J, do Carmo Ara\u00fajo M, Oliveira L, Chiesa J, Morsch VM, Leal DB, Schetinger MR (2013) Ectoenzymes and cholinesterase activity and biomarkers of oxidative stress in patients with lung cancer. Mol Cell Biochem 374:137\u2013148. https:\/\/doi.org\/10.1007\/s11010-012-1513-6","journal-title":"Mol Cell Biochem"},{"key":"9686_CR38","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s11302-016-9505-8","volume":"12","author":"F Figueir\u00f3","year":"2016","unstructured":"Figueir\u00f3 F, de Oliveira CP, Bergamin LS, Rockenbach L, Mendes FB, Jandrey EH, Moritz CE, Pettenuzzo LF, S\u00e9vigny J, Guterres SS, Pohlmann AR, Battastini AM (2016) Methotrexate up-regulates ecto-5\u2032-nucleotidase\/CD73 and reduces the frequency of T lymphocytes in the glioblastoma microenvironment. Purinergic Signal 12:303\u2013312. https:\/\/doi.org\/10.1007\/s11302-016-9505-8","journal-title":"Purinergic Signal"},{"key":"9686_CR39","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3892\/or.2011.1274","volume":"26","author":"Y Tada","year":"2011","unstructured":"Tada Y, Yokomizo A, Shiota M, Song Y, Kashiwagi E, Kuroiwa K, Oda Y, Naito S (2011) Ectonucleoside triphosphate diphosphohydrolase 6 expression in testis and testicular cancer and its implication in cisplatin resistance. Oncol Rep 26:161\u2013167. https:\/\/doi.org\/10.3892\/or.2011.1274","journal-title":"Oncol Rep"},{"key":"9686_CR40","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1111\/j.1349-7006.2009.01219.x","volume":"100","author":"E Braganhol","year":"2009","unstructured":"Braganhol E, Morrone FB, Bernardi A, Huppes D, Meurer L, Edelweiss MI, Lenz G, Wink MR, Robson SC, Battastini AM (2009) Selective NTPDase2 expression modulates in vivo rat glioma growth. Cancer Sci 100:1434\u20131442. https:\/\/doi.org\/10.1111\/j.1349-7006.2009.01219.x","journal-title":"Cancer Sci"},{"key":"9686_CR41","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11302-011-9276-1","volume":"8","author":"E Braganhol","year":"2012","unstructured":"Braganhol E, Zanin RF, Bernardi A, Bergamin LS, Cappellari AR, Campesato LF, Morrone FB, Campos MM, Calixto JB, Edelweiss MI, Wink MR, S\u00e9vigny J, Robson SC, Battastini AM (2012) Overexpression of NTPDase2 in gliomas promotes systemic inflammation and pulmonary injury. Purinergic Signal 8:235\u2013243. https:\/\/doi.org\/10.1007\/s11302-011-9276-1","journal-title":"Purinergic Signal"},{"key":"9686_CR42","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.neuroscience.2005.11.039","volume":"138","author":"MR Wink","year":"2006","unstructured":"Wink MR, Braganhol E, Tamajusuku ASK, Lenz G, Zerbini LF, Libermann TA, S\u00e9vigny J, Battastini AM, Robson SC (2006) Nucleoside triphosphate diphosphohydrolase-2 (NTPDase2\/CD39L1) is the dominant ectonucleotidase expressed by rat astrocytes. Neuroscience 138:421\u2013432. https:\/\/doi.org\/10.1016\/j.neuroscience.2005.11.039","journal-title":"Neuroscience"},{"key":"9686_CR43","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.bbagen.2007.05.004","volume":"1770","author":"A Buffon","year":"2007","unstructured":"Buffon A, Wink MR, Ribeiro BV et al (2007) NTPDase and 5\u2032 ecto-nucleotidase expression profiles and the pattern of extracellular ATP metabolism in the Walker 256 tumor. Biochim Biophys Acta - Gen Subj 1770:1259\u20131265. https:\/\/doi.org\/10.1016\/j.bbagen.2007.05.004","journal-title":"Biochim Biophys Acta - Gen Subj"},{"key":"9686_CR44","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.lfs.2006.11.024","volume":"80","author":"A Buffon","year":"2007","unstructured":"Buffon A, Ribeiro VB, Wink MR, Casali EA, Sarkis JJ (2007) Nucleotide metabolizing ecto-enzymes in Walker 256 tumor cells: molecular identification, kinetic characterization and biochemical properties. Life Sci 80:950\u2013958. https:\/\/doi.org\/10.1016\/j.lfs.2006.11.024","journal-title":"Life Sci"},{"key":"9686_CR45","doi-asserted-by":"publisher","unstructured":"Bracco PA, Bertoni APS, Wink MR (2014, 2014) NTPDase5\/PCPH as a new target in highly aggressive tumors: a systematic review. Biomed Res Int. https:\/\/doi.org\/10.1155\/2014\/123010","DOI":"10.1155\/2014\/123010"},{"key":"9686_CR46","first-page":"1249","volume":"19","author":"JG P\u00e1ez","year":"2001","unstructured":"P\u00e1ez JG, Recio JA, Rouzaut A, Notario V (2001) Identity between the PCPH proto-oncogene and the CD39L4 (ENTPD5) ectonucleoside triphosphate diphosphohydrolase gene. Int J Oncol 19:1249\u20131254","journal-title":"Int J Oncol"},{"key":"9686_CR47","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10142-010-0200-5","volume":"11","author":"M Mikula","year":"2011","unstructured":"Mikula M, Rubel T, Karczmarski J et al (2011) Integrating proteomic and transcriptomic high-throughput surveys for search of new biomarkers of colon tumors. Funct Integr Genomics 11:215\u2013224. https:\/\/doi.org\/10.1007\/s10142-010-0200-5","journal-title":"Funct Integr Genomics"},{"key":"9686_CR48","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10585-018-9874-1","volume":"35","author":"AJ Gareau","year":"2018","unstructured":"Gareau AJ, Brien C, Gebremeskel S, Liwski RS, Johnston B, Bezuhly M (2018) Ticagrelor inhibits platelet\u2013tumor cell interactions and metastasis in human and murine breast cancer. Clin Exp Metastasis 35:25\u201335. https:\/\/doi.org\/10.1007\/s10585-018-9874-1","journal-title":"Clin Exp Metastasis"}],"container-title":["Purinergic Signalling"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-019-09686-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11302-019-09686-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-019-09686-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,17]],"date-time":"2021-01-17T00:12:56Z","timestamp":1610842376000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11302-019-09686-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,18]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["9686"],"URL":"https:\/\/doi.org\/10.1007\/s11302-019-09686-x","relation":{},"ISSN":["1573-9538","1573-9546"],"issn-type":[{"value":"1573-9538","type":"print"},{"value":"1573-9546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,18]]},"assertion":[{"value":"3 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures in this study were approved by the Ethics Committee of UFRGS (CEP\/UFRGS) of the Universidade Federal de Rio Grande do Sul, under protocol number 1.979.570.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}